These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 31454660

  • 1. Analysis of Spatial Dose-Volume Relationships and Decline in Sexual Function Following Permanent Brachytherapy for Prostate Cancer.
    Peng LC, Mian OY, Lakshminarayanan P, Huang P, Bae HJ, Robertson S, Habtu T, Narang A, Agarwal S, Greco S, Tran P, McNutt T, DeWeese TL, Song DY.
    Urology; 2020 Jan; 135():111-116. PubMed ID: 31454660
    [Abstract] [Full Text] [Related]

  • 2. Dose to the penile bulb and individual patient anatomy are predictive of erectile dysfunction in men treated with 125I low dose rate brachytherapy for localized prostate cancer.
    Chasseray M, Dissaux G, Bourbonne V, Boussion N, Goasduff G, Malloreau J, Malhaire JP, Fournier G, Tissot V, Pradier O, Valeri A, Schick U.
    Acta Oncol; 2019 Jul; 58(7):1029-1035. PubMed ID: 30761939
    [Abstract] [Full Text] [Related]

  • 3. Erectile function after permanent prostate brachytherapy.
    Merrick GS, Butler WM, Galbreath RW, Stipetich RL, Abel LJ, Lief JH.
    Int J Radiat Oncol Biol Phys; 2002 Mar 15; 52(4):893-902. PubMed ID: 11958881
    [Abstract] [Full Text] [Related]

  • 4. Erectile function after prostate brachytherapy.
    Merrick GS, Butler WM, Wallner KE, Galbreath RW, Anderson RL, Kurko BS, Lief JH, Allen ZA.
    Int J Radiat Oncol Biol Phys; 2005 Jun 01; 62(2):437-47. PubMed ID: 15890585
    [Abstract] [Full Text] [Related]

  • 5. A comparison of radiation dose to the bulb of the penis in men with and without prostate brachytherapy-induced erectile dysfunction.
    Merrick GS, Wallner K, Butler WM, Galbreath RW, Lief JH, Benson ML.
    Int J Radiat Oncol Biol Phys; 2001 Jul 01; 50(3):597-604. PubMed ID: 11395225
    [Abstract] [Full Text] [Related]

  • 6. Low-Dose-Rate Brachytherapy Combined With Ultrahypofractionated Radiation Therapy for Clinically Localized, Intermediate-Risk Prostate Cancer: Results From a Prospective Trial.
    Kollmeier MA, McBride S, Varghese M, Debonis D, Zhang Z, Cohen G, Damato AL, Mychalczak B, Gewanter R, Zelefsky MJ.
    Int J Radiat Oncol Biol Phys; 2020 Nov 15; 108(4):905-913. PubMed ID: 32505609
    [Abstract] [Full Text] [Related]

  • 7. Long-term urinary, sexual, and rectal morbidity in patients treated with iodine-125 prostate brachytherapy followed up for a minimum of 5 years.
    Stone NN, Stock RG.
    Urology; 2007 Feb 15; 69(2):338-42. PubMed ID: 17320674
    [Abstract] [Full Text] [Related]

  • 8. An analysis of erectile function after intensity modulated radiation therapy for localized prostate carcinoma.
    Brown MW, Brooks JP, Albert PS, Poggi MM.
    Prostate Cancer Prostatic Dis; 2007 Feb 15; 10(2):189-93. PubMed ID: 17189954
    [Abstract] [Full Text] [Related]

  • 9. Sexual potency preservation and quality of life after prostate brachytherapy and low-dose tadalafil.
    Pugh TJ, Mahmood U, Swanson DA, Munsell MF, Wang R, Kudchadker RJ, Bruno TL, Frank SJ.
    Brachytherapy; 2015 Feb 15; 14(2):160-5. PubMed ID: 25255712
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A comparison of radiation dose to the neurovascular bundles in men with and without prostate brachytherapy-induced erectile dysfunction.
    Merrick GS, Butler WM, Dorsey AT, Lief JH, Donzella JG.
    Int J Radiat Oncol Biol Phys; 2000 Nov 01; 48(4):1069-74. PubMed ID: 11072164
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Sexual function and the use of medical devices or drugs to optimize potency after prostate brachytherapy.
    Whaley JT, Levy LB, Swanson DA, Pugh TJ, Kudchadker RJ, Bruno TL, Frank SJ.
    Int J Radiat Oncol Biol Phys; 2012 Apr 01; 82(5):e765-71. PubMed ID: 22300559
    [Abstract] [Full Text] [Related]

  • 14. Effect of aging and long-term erectile function after iodine-125 prostate brachytherapy.
    Keyes M, Pickles T, Crook J, McKenzie M, Cheung A, Spadinger I, LaPointe V, Bachand WF, Morris J.
    Brachytherapy; 2015 Apr 01; 14(3):334-41. PubMed ID: 25684438
    [Abstract] [Full Text] [Related]

  • 15. The importance of radiation doses to the penile bulb vs. crura in the development of postbrachytherapy erectile dysfunction.
    Merrick GS, Butler WM, Wallner KE, Lief JH, Anderson RL, Smeiles BJ, Galbreath RW, Benson ML.
    Int J Radiat Oncol Biol Phys; 2002 Nov 15; 54(4):1055-62. PubMed ID: 12419431
    [Abstract] [Full Text] [Related]

  • 16. Erectile function durability following permanent prostate brachytherapy.
    Taira AV, Merrick GS, Galbreath RW, Butler WM, Wallner KE, Kurko BS, Anderson R, Lief JH.
    Int J Radiat Oncol Biol Phys; 2009 Nov 01; 75(3):639-48. PubMed ID: 19303721
    [Abstract] [Full Text] [Related]

  • 17. A prospective longitudinal survey of erectile dysfunction in patients with localized prostate cancer treated with permanent prostate brachytherapy.
    Matsushima M, Kikuchi E, Maeda T, Nakashima J, Sugawara A, Ando T, Mizuno R, Nagata H, Miyajima A, Shigematsu N, Oya M.
    J Urol; 2013 Mar 01; 189(3):1014-8. PubMed ID: 23017516
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. There is no correlation between erectile dysfunction and dose to penile bulb and neurovascular bundles following real-time low-dose-rate prostate brachytherapy.
    Solan AN, Cesaretti JA, Stone NN, Stock RG.
    Int J Radiat Oncol Biol Phys; 2009 Apr 01; 73(5):1468-74. PubMed ID: 18922652
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.